HSDT trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HSDT achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Solana Company (HSDT) has a Wall Street consensus price target of N/A, based on estimates from 5 covering analysts. The company has a market capitalization of $168M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, HSDT trades at a trailing P/E of -1.6x. Analysts expect EPS to grow +17.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 STIMNeuronetics, Inc. | $200M | $2.88 | $5.00 | +73.6% | Buy | — | 7 |
 LFSTLifeStance Health Group, Inc. | $4.7B | $12.08 | $13.86 | +14.7% | Buy | 75.3x | 11 |
 MBOTMicrobot Medical Inc. | $60M | $1.31 | $5.50 | +319.8% | Buy | — | 3 |
 GKOSGlaukos Corporation | $9.1B | $153.49 | $190.75 | +24.3% | Buy | — | 25 |
 NVCRNovocure Ltd | $1.9B | $16.25 | $26.00 | +60.0% | Buy | — | 15 |
 LIVNLivaNova PLC | $4.2B | $77.16 | $88.50 | +14.7% | Buy | 17.7x | 15 |
 MDTMedtronic plc | $114.7B | $89.30 | $98.00 | +9.7% | Buy | 14.9x | 51 |
 BSXBoston Scientific Corporation | $66.3B | $44.62 | $66.30 | +48.6% | Buy | 13.6x | 44 |
 ABTAbbott Laboratories | $180.3B | $103.53 | $121.50 | +17.4% | Buy | 18.8x | 41 |
 SYKStryker Corporation | $104.8B | $273.40 | $372.39 | +36.2% | Buy | 18.2x | 52 |
Quick answers to the most common questions about buying HSDT stock.
The consensus price target for HSDT is $N/A, close to the current price of $2.88 (N/A% implied move). Based on 5 analyst estimates, the stock appears fairly valued near current levels.
HSDT has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
HSDT's current price is $2.88 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for HSDT, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
HSDT is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HSDT stock forecast based on 5 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
HSDT appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HSDT analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.